The registration includes access to the PRE-MEETING: DIABETIC BONE DISEASES on 21 August

Abstract submission


The bone marrow adipose tissue (BMA) represets almost 70% of bone marrow cavity and it derives from skeletal stem cells that in addition to be able to differentiate into adipocytes, can differentiate into osteoblastic bone forming cells. A number of studies thus suggest a close relationship between energy metabolism, bone marrow adipocytes and bone formation by osteoblastic cells. Moreover, several epidemiological and clinical studies have demonstrated that bone fracture is an important complication of both type I and type II diabetes. Unfortunately, classical risk factors of age-related osteoporosis that predict osteoporotic fractures do not apply to diabetic patients and thus there is a need for more understanding of the pathophysiology of bone fracture and ”diabetic bone disease”. Further, increased BMA has also been shown in cancer patients after chemotherapy treatment interfering with blood production in bone marrow cavity. Thus, these areas of research increase attention of several scientists all over the world. 


Guidelines for submission of abstract:

Abstract text: maximum 300 words

Deadline for submission abstract: EXTENDED TO 30 JUNE, 2019 

Deadline for notification of accepted for ORAL/Poster or rejected: EXTENDED TO 8 July, 2019

Deadline for earlybird: Extended to 15 June, 2019

Deadline for notification of the final program including presentation time: TBC 


Online abstract submission:

Please click here to get access to the online abstract submission

Online user: 1